Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Xiao Mou Peng"'
Autor:
Ying-Peng Peng, Rong Wang, Qiao-Dan Liu, Xi-Wei Xu, Wei Wei, Xiao-Tao Huang, Xiao-Mou Peng, Zhi-Gang Liu
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Purpose: To investigate the prognostic significance of tumor mutational burden (TMB) combined with specific prognosis-related gene mutations in immunotherapy for recurrent and metastatic head and neck squamous cell carcinoma (r/m HNSCC).Methods: One
Externí odkaz:
https://doaj.org/article/996506877b214676a7c246799f523393
Publikováno v:
Translational Cancer Research. 12:1073-1087
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c393f3afa6d009c9859d676446706f2
https://doi.org/10.21037/tcr-22-2562
https://doi.org/10.21037/tcr-22-2562
Background: Soluble CD14 (sCD14) and T helper 17-related interleukins (IL-17 and IL-22) in bronchoalveolar lavage fluid (BALF) are preliminarily reported to be increased in pulmonary tuberculosis (PTB). Their significances to the bacteriological conf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b0a419be68969d2c355d06928195554
https://doi.org/10.21203/rs.3.rs-153808/v1
https://doi.org/10.21203/rs.3.rs-153808/v1
Background: Since December 2019, COVID-19 has been confirmed in more than18.8 million patients and leads to 0.70 million deaths worldwide. The mortality and disease severity predictors of COVID-19 have been investigated in many studies. However, they
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cc79f0c4a2107b4f1ef1ce17e14f039
https://doi.org/10.21203/rs.3.rs-104036/v1
https://doi.org/10.21203/rs.3.rs-104036/v1
Autor:
Xiao Mou Peng1 xiaomoupeng@hotmail.com, Yang Su Huang1, Hui Hui Ma1, Lin Gu1, Qi Feng Xie1, Zhi Liang Gao1
Publikováno v:
Liver International. Apr2006, Vol. 26 Issue 3, p326-333. 8p. 1 Diagram, 4 Charts.
Publikováno v:
Virus genes. 52(5)
The cellular proteasomes presumably inhibit the replication of hepatitis B virus (HBV) due to degradation of the viral core protein (HBcAg). Common proteasome inhibitors, however, either enhance or inhibit HBV replication. In this study, the exact de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad2b3b2de3b1342a576ac81463c6b8d1
https://pubmed.ncbi.nlm.nih.gov/27105855
https://pubmed.ncbi.nlm.nih.gov/27105855
Publikováno v:
Hepatology Research. 43:208-216
AIM The mechanisms underlying development of chronic hepatitis B virus (HBV) infection are related to immune tolerance, but are as yet incompletely understood. Furin has been found to be essential for maintenance of peripheral immune tolerance mediat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6451c1ea560ff57ac0f5ed229a0c143e
https://doi.org/10.1111/j.1872-034x.2012.01051.x
https://doi.org/10.1111/j.1872-034x.2012.01051.x
Publikováno v:
Hepatology. 50:763-771
Hepatitis B e antigen (HBeAg) is a viral strategy of immune response evasion associated with hepatitis B virus (HBV) persistence. Spontaneous HBeAg seroconversion is usually accompanied by liver disease remission. Unfortunately, this goal is difficul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9e3bd4fe93acacfca0286ecd8aea937
https://doi.org/10.1002/hep.23062
https://doi.org/10.1002/hep.23062
Publikováno v:
International Journal of Immunogenetics. 34:341-346
The influence of human genetics on the natural history of hepatitis B virus (HBV) infection may be diminished in endemic areas because infection at a young age predisposes to chronic HBV infection. The present study aimed to address this issue throug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b0f6d6fc2b35f53c0ab0a8c013d3fc2
https://doi.org/10.1111/j.1744-313x.2007.00696.x
https://doi.org/10.1111/j.1744-313x.2007.00696.x
Publikováno v:
Liver International. 26:326-333
Background: The influence of interleukin-10 (IL-10) gene promoter polymorphisms on the mode and sequel of HBeAg seroconversion (a favorable event usually) in patients with chronic Hepatitis B virus (HBV) infection has not been clarified. Patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ff839220ee03494dbe493d1dcf252df
https://doi.org/10.1111/j.1478-3231.2005.01241.x
https://doi.org/10.1111/j.1478-3231.2005.01241.x